Features
Get A Demo
Plans
Sign Up
Login
All Federal Grant Programs
Drug Use and Addiction Research Programs
Posted
8/31/18
Assistance Listing Number
93.279
Overview
Grant Opportunities
27
Grant Awards
>10k
Federal Agency
National Institutes of Health
Applicant Types
Not listed
Beneficiary Types
Not listed
Additional Information
Not listed
Popular Federal Grant Opportunities
Not listed
Popular Federal Grant Awards
Not listed
Name
Description
Awardee
Assistance Type
Dollars Obligated
(Click to sort descending)
Award Date
(Click to sort descending)
Updated At
(Click to sort descending)
R15DA050178
AN ANIMAL MODEL OF GAMBLING IN A LABORATORY-BASED TOKEN ECONOMY
The Reed Institute
Project Grant
$465.3k
5/1/20
7/11/24
1R01DA022199010
--
None
Project Grant
$366.1k
9/15/06
9/15/06
5R01DA011928080
--
None
Project Grant
$338.0k
7/15/05
7/15/05
R01DA006227
CNS MECHANISMS IN COCAINE-RELATED SUDDEN DEATH
University Of Miami
Project Grant
$2.0m
4/1/90
7/18/17
1R01DA020852010
--
None
Project Grant
$409.2k
9/15/05
9/15/05
Name
Description
Solicitation Number
Federal Agency
Due Date
(Click to sort descending)
Posted Date
(Click to sort descending)
HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R33 Clinical Trial Optional)
This Federal Grant Opportunity, RFA-DA-23-054, is part of the HEAL Initiative and seeks to fund translational research focused on addressing the overdose crisis and the intersection of pain and opioid use disorder. The funding opportunity is open to a wide range of applicant types, including tribal governments, higher education institutions, small businesses, and non-profits. Key objectives include developing and disseminating evidence-based interventions to reduce overdose deaths. The application deadline is December 16, 2024, and the opportunity is expected to run for 2 years (FY23 and FY24). The funding for this opportunity is provided by the National Institutes of Health (NIH), specifically the National Institute on Drug Abuse (NIDA). Typical award values under this program range from smaller exploratory grants around $50,000 to large multi-year projects exceeding $3 million in total costs, with most awards falling between $400,000-$800,000. The research activities are generally expected to be conducted at the facilities of the recipient organizations across the United States.
RFA-DA-23-054
Department of Health and Human Services National Institutes of Health
12/16/24
8/3/22
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
The purpose of the NIH Research Conference Grant (R13) is to support high quality conferences that are relevant to the public health and to the scientific mission of the participating Institutes and Centers.
PA-20-207
Department of Health and Human Services National Institutes of Health
2/10/21
5/8/20
Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R43/R44 - Clinical Trial Optional)
This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) proposing research projects, directed towards commercialization, for the development of novel, evidence-based, FDA-regulated medical products addressing the needs of patients suffering from opioid use disorders (OUD) and stimulant use disorders (StUD). Applications received under this FOA may fall within two scientific areas, namely: (1) pharmacotherapeutics (small molecules and biologics; and (2) medical therapeutic and diagnostic devices, including software as a medical device. This FOA strives to contribute to the effort against national opioid and psychostimulant emergency and offer new medical products for individuals, families, and communities affected by this devastating crisis.
RFA-DA-23-021
Department of Health and Human Services National Institutes of Health
2/14/25
3/28/22
HEAL Initiative: Therapeutics Development for Opioid Use Disorder in Patients with Co-occurring Mental Disorders (UG3/UH3 - Clinical Trial Optional)
THE PURPOSE OF THIS FOA IS TO SUPPORT RESEARCH THAT ACCELERATES THE DISCOVERY AND DEVELOPMENT OF SAFE AND EFFECTIVE THERAPEUTICS FOR OUD IN PATIENTS WITH CO-OCCURRING COMD. THE THERAPEUTIC INTERVENTIONS MAY INCLUDE MEDICATIONS, DEVICES, OR DIGITAL THERAPEUTICS. THE GOAL IS TO SUPPORT RESEARCH THAT ADDRESSES THE URGENT NEED TO HAVE SAFE AND EFFECTIVE THERAPEUTICS FOR OUD IN PATIENTS WITH CO-OCCURRING COMD.
RFA-DA-23-049
Department of Health and Human Services National Institutes of Health
2/2/23
7/28/22
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31-Diversity)
The National Institutes of Health (NIH) is offering the Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research. The purpose of this grant is to enhance the diversity of the health-related research workforce by supporting the research training of predoctoral students from diverse backgrounds. The grant will provide individualized, mentored research training to promising predoctoral students as they conduct well-defined research projects in scientific health-related fields. Applications are due by February 21, 2025. The grant awards are expected to provide funding to support the research training of predoctoral students. Award amounts and the number of awards are not specified in the details provided. The research activities are to be conducted at the recipient organizations' facilities across the United States.
PA-23-271
Department of Health and Human Services National Institutes of Health
2/21/25
9/12/23